These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17449332)

  • 1. Drop-out rates of cancer patients participating in longitudinal RCTs.
    Mathibe LJ
    Contemp Clin Trials; 2007 Jul; 28(4):340-2. PubMed ID: 17449332
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
    Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
    J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does analysis using "last observation carried forward" introduce bias in dementia research?
    Molnar FJ; Hutton B; Fergusson D
    CMAJ; 2008 Oct; 179(8):751-3. PubMed ID: 18838445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy in patients with colorectal carcinoma: applicability of data from clinical trials for the individual patient].
    Thürmann PA
    Zentralbl Chir; 2008 Feb; 133(1):25-30. PubMed ID: 18278698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of randomized controlled trials.
    Stanley K
    Circulation; 2007 Apr; 115(13):1819-22. PubMed ID: 17404173
    [No Abstract]   [Full Text] [Related]  

  • 7. Sources of bias in clinical trials.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):595-6. PubMed ID: 21967950
    [No Abstract]   [Full Text] [Related]  

  • 8. The number, content, and quality of randomized controlled trials in the prevention and care of injuries.
    Stelfox HT; Goverman J
    J Trauma; 2008 Dec; 65(6):1488-93. PubMed ID: 19077647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The problem of randomization in psychotherapy studies].
    Klingberg S; Buchkremer G
    Psychother Psychosom Med Psychol; 1999 Feb; 49(2):68-70. PubMed ID: 10098395
    [No Abstract]   [Full Text] [Related]  

  • 10. [1998 oncologic highlights: difficult choices--no inferior quality].
    Fey MF
    Schweiz Med Wochenschr; 1999 Jan; 129(1-2):11-3. PubMed ID: 10065495
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drop-out from treatment for the eating disorders: a problem for clinicians and researchers.
    Campbell M
    Eur Eat Disord Rev; 2009 Jul; 17(4):239-42. PubMed ID: 19475635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer treatment and the older patient.
    Trimble EL; Christian MC
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1956-7. PubMed ID: 16609002
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of massage therapy in cancer care.
    Myers CD; Walton T; Small BJ
    Hematol Oncol Clin North Am; 2008 Aug; 22(4):649-60, viii. PubMed ID: 18638693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of intention to treat in analysis of noninferiority studies.
    Wiens BL; Zhao W
    Clin Trials; 2007; 4(3):286-91. PubMed ID: 17715258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer.
    Kim MK; Lee JL; Hyun MS; Do YR; Song HS; Kim JG; Bae SH; Ryoo HM; Park KU; Lee KH
    Jpn J Clin Oncol; 2008 Jan; 38(1):64-70. PubMed ID: 18238880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-arm clinical trials of new agents: some design considerations.
    Freidlin B; Korn EL; Gray R; Martin A
    Clin Cancer Res; 2008 Jul; 14(14):4368-71. PubMed ID: 18628449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introduction to randomized trials: attrition bias].
    Simon EG; Fouché CJ; Perrotin F
    Gynecol Obstet Fertil; 2012 Jan; 40(1):64-5. PubMed ID: 22192692
    [No Abstract]   [Full Text] [Related]  

  • 19. Thinking while balancing: what to do about replacing dropouts.
    Shader RI; Harmatz JS; Greenblatt DJ
    J Clin Psychopharmacol; 1994 Aug; 14(4):229. PubMed ID: 7962677
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial imputation approach to analysis of repeated measurements with dependent drop-outs.
    Wei L; Shih WJ
    Stat Med; 2001 Apr; 20(8):1197-214. PubMed ID: 11304736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.